MASIMO CORPORATION (NASDAQ: MASI)

MASIMO CORPORATION

NASDAQ: MASI (Masimo Corporation)

Last update: 2 days ago, 6:31PM

124.10

3.49 (2.89%)

Add to watchlist

Market Trend

		Short Term	Medium Term
Industry	Medical Devices (US)	Bullish	Bearish
	Medical Devices (Global)	Bullish	Bearish
Stock	Masimo Corporation	Mixed	Bearish

Analyst Consensus

Strong Sell

Sell

Neutral

Buy

Strong Buy

3 Buy, 1 Hold

Avg. Price @ Call: 134.25

Similar Stocks

Stock	Market Cap	DY	P/E	P/B
MASI	7 B	-	84.42	4.69
LIVN	3 B	-	-	2.75
NVCR	2 B	-	-	4.93
ATEC	2 B	-	-	42.39
INMD	2 B	-	8.75	1.93
ESTA	2 B	-	-	27.98

Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Sector	Healthcare
Industry	Medical Devices
Investment Style	Small Core

Ownership

Name	Date	Shares Held
Politan Capital Management Lp	31 Mar 2024	4,713,518
Farallon Capital Management Llc	31 Mar 2024	1,489,563
Liontrust Investment Partners Llp	31 Mar 2024	825,529
Holocene Advisors, Lp	31 Mar 2024	778,414

52 Weeks Range	75.22 - 169.58
Price Target Range	126.00 - 170.00
High	170.00 (Stifel, 36.99%)	Buy
Median	163.00 (31.35%)
Low	126.00 (Piper Sandler, 1.53%)	Hold
Average	155.50 (25.30%)
Total	3 Buy, 1 Hold

Firm	Date	Target Price	Call	Price @ Call
Piper Sandler	08 May 2024	126.00 (1.53%)	Hold	120.02
Piper Sandler	26 Feb 2024	117.00 (-5.72%)	Hold	130.69
Stifel	15 Apr 2024	170.00 (36.99%)	Buy	138.11
Stifel	25 Mar 2024	148.00 (19.26%)	Hold	139.43
BTIG	25 Mar 2024	166.00 (33.76%)	Buy	139.43
Wells Fargo	25 Mar 2024	160.00 (28.93%)	Buy	139.43

No data within this time range.

Date	Type	Details
16 May 2024	Announcement	Masimo and Denon Introduce White PerL™ and PerL Pro™ Earbuds, Redefining Style and Customization in Personalized Audio
08 May 2024	Announcement	Masimo to Present in BofA Securities Health Care Conference
07 May 2024	Announcement	Masimo Reports First Quarter 2024 Financial Results
06 May 2024	Announcement	Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
23 Apr 2024	Announcement	Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
16 Apr 2024	Announcement	Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
01 Apr 2024	Announcement	Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
25 Mar 2024	Announcement	Politan Nominates Two Independent Candidates for Masimo Board
22 Mar 2024	Announcement	Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
19 Mar 2024	Announcement	Masimo Named One of Fast Company’s Most Innovative Companies in North America
07 Mar 2024	Announcement	Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
04 Mar 2024	Announcement	Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
27 Feb 2024	Announcement	Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
20 Feb 2024	Announcement	Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2024	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No data

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)